Axsome Therapeutics

AXSM • NASDAQ • Stock Fundamentals

Axsome Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Herriot Tabuteau, with a market cap of $13.1B.

Market Cap$13.1B

Employees569.0

CEOHerriot Tabuteau

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 4, 2026 · 1 month 10 days agoQ1 2026

Next EarningsAug 3, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Axsome Therapeutics

Axsome Therapeutics (AXSM) has a market capitalization of $13.1B and trades on NASDAQ.

Axsome Therapeutics has approximately 569 employees.